|
| Exchange Disseminated Time 27/10/2016 08:06:38 | Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 26, 2016, has approved the following;
1. The Board has pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, would like to inform that the Bliss GVS Healthcare Ltd, the Kenyan step down subsidiary of M/s Bliss GVS Pharma Ltd, has won an Annual Contract worth USD 38.76 Million (USD Thirty Eight Million Seven Hundred Sixty Thousand Only) for a period of Two Years, from a consortium of leading Insuremce firms in Kenya, that includes insurance companies AAR, Jubilee & UFA for provision of In -patient and Out-patient health care services for approximately 125,000 principal members and their dependents.
2. The Board reconstituted the Audit Committee.
3. The Board approved the terms and conditions of the Loan proposal of Rs. 68.00 crores from IDFC/ICBC Bank. The Board forwarded tlie Loan proposal for review of the audit committee and submit their review report to the Board members by way circulation within 7-days time.
4. The Board took on record and recommended for approval of the members for the authority to deal with the properties of the company, etc as per & mentioned in section 180(l)(a) of the Comparues Act, 2013 and seek the approval of the members by way of postal ballot as per section 110 of the Companies Act, 2013. |
|
|